Matthew T. Rondina, MD, MS has accepted the position of Director of the Molecular Medicine Program (U2M2).
Dr. Rondina is a natural fit to maintain the momentum of U2M2. He has a deep commitment to the program, strong relationships with the faculty and staff, extensive knowledge of the program’s administrative operations and broad clinical and translational ties throughout the institution. These skills all serve as a perfect foundation for his new role as director of the U2M2 program. He joined the Internal Medicine faculty in 2007 and became a U2M2 investigator in 2011. He has published over 100 peer-reviewed articles and has been continuously funded for over a decade by federal (NIH, VA), private, and industrial agencies. His knowledge in fundamental basic science and translational research will be a huge asset for U2M2 as the program grows and builds stronger relationships with home colleges and departments.
Thank you to A. Lorris Betz, M.D. for his support of this appointment and many thanks to Andrew S. Weyrich, Ph.D. and H. Joseph Yost, Ph.D., who have been serving as the interim co-directors of the Molecular Medicine Program.
Dr. Rondina will be supported in his leadership by a new executive committee, which he will announce in the coming weeks.